Carolyn L Cannon

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Cystic Fibrosis

Pseudomonas Aeruginosa

Gold Nanoparticles

Top Venues

Molecular pharmaceutics

Pathogens (Basel, Switzerland)

ACS applied materials & interfaces

Texas A&M University Health Sciences Center

University of Texas Graduate School of Biomedical Sciences at Houston (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Texas A&M University Health Sciences Center Aug 1o 2014

United States

Associate Professor :: Microbial Pathogenesis and immunology

Education History

University of Texas Graduate School of Biomedical Sciences at Houston

United States

PHD :: Physiology and Cell Biology

Publications

Qingquan Chen, Marleini Ilanga, Sabona B Simbassa, Bhagath Chirra, Kush N Shah, Carolyn L Cannon
Synergistic Antimicrobial Effects of Ibuprofen Combined with Standard-of-Care Antibiotics against Cystic Fibrosis Pathogens. Biomedicines 11 (11) (2023)
Akshi Singla, Sabona B Simbassa, Bhagath Chirra, Anirudh Gairola, Marie R Southerland, Kush N Shah, Robert E Rose, Qingquan Chen, Ahmed Basharat, Jaime Baeza, Rohit Raina, Morgan J Chapman, Adel M Hassan, Ivan Ivanov, Anindito Sen, Hung-Jen Wu, Carolyn L Cannon
Hetero-Multivalent Targeted Liposomal Drug Delivery to Treat Pseudomonas aeruginosa Infections. ACS applied materials & interfaces 14 (36) (2022)
Shaorong Chen, Dongmei Zhang, Alexandria-Jade Roberts, Hsueh-Chung Lu, Carolyn L Cannon, Qing-Ming Qin, Paul de Figueiredo
Host Protease Activity on Bacterial Pathogens Promotes Complement and Antibiotic-Directed Killing. Pathogens (Basel, Switzerland) 10 (11) (2021)
Qingquan Chen, Kush N Shah, Fuwu Zhang, Adam J Salazar, Parth N Shah, Richen Li, James C Sacchettini, Karen L Wooley, Carolyn L Cannon
Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa. Molecular pharmaceutics 16 (4) (2019)